Literature DB >> 20507285

Ultrasound measurement of peripheral endothelial dysfunction in type 2 diabetic patients: correlation with risk factors.

Marijan Bosevski1, Ljubica Georgievska-Ismail.   

Abstract

The purpose of the study was to assess the endothelial dysfunction (ED) in type 2 diabetic patients ultrasonographically and estimate the correlation of ED with glycemia and other cardio-metabolic risk factors. 171 patient (age 60.0 + 8.5 years) with diagnosed type 2 diabetes and coronary artery disease (CAD) were randomly included in a cross sectional study. B-mode ultrasound system with a linear transducer of 7.5 MHz was used for evaluation of flow-mediated vasodilation in brachial artery (FMV). FMV was presented as a change of brachial artery diameter at rest and after limb ischemia, previously provoked by cuff inflation. Peripheral ED was found in 77.2% (132 patients). Multivariate logistic regression model defined: age (OR 1.071, 95% CI 1.003 1,143) and plasma cholesterol (OR 4.083 95% CI 1.080 17,017) as determinants for ED. Linear multivariate analysis presented duration of diabetes (Beta 0.173, Sig 0.024), and glycemia (Beta 0.132, Sig 0.044) to be associated independently with FMV value. Estimated factors influencing FMV, might be potential therapeutic targets for presented endothelial dysfunction in type 2 diabetic patients with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507285      PMCID: PMC5509406          DOI: 10.17305/bjbms.2010.2699

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  19 in total

1.  Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study.

Authors:  G Neil Thomas; Ping Chook; Mu Qiao; Xin S Huang; Hok C Leong; David S Celermajer; Kam S Woo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

Review 2.  Ageing of the conduit arteries.

Authors:  S E Greenwald
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli.

Authors:  P Leeson; S Thorne; A Donald; M Mullen; P Clarkson; J Deanfield
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

4.  Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

Authors:  C G Schalkwijk; D C Poland; W van Dijk; A Kok; J J Emeis; A M Dräger; A Doni; V W van Hinsbergh; C D Stehouwer
Journal:  Diabetologia       Date:  1999-03       Impact factor: 10.122

5.  Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.

Authors:  Antonio Ceriello; Roberta Assaloni; Roberto Da Ros; Amabile Maier; Ludovica Piconi; Lisa Quagliaro; Katherine Esposito; Dario Giugliano
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

Review 6.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 7.  Endothelial function: a critical determinant in atherosclerosis?

Authors:  Ulf Landmesser; Burkhard Hornig; Helmut Drexler
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

8.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction.

Authors:  D S Celermajer; K E Sorensen; C Bull; J Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

9.  Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease?

Authors:  M Bosevski; V Borozanov; S Tosev; Lj Georgievska-Ismail
Journal:  Int J Cardiol       Date:  2007-10-26       Impact factor: 4.164

10.  Arterial dysfunction in syndrome X: results of arterial reactivity and pulse wave propagation tests.

Authors:  M Kidawa; M Krzeminska-Pakula; J Z Peruga; J D Kasprzak
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

View more
  2 in total

1.  Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4.

Authors:  Sokho Kim; Jungkee Kwon
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

Review 2.  Progress on diabetic cerebrovascular diseases.

Authors:  Houguang Zhou; Xiaoming Zhang; Jianfeng Lu
Journal:  Bosn J Basic Med Sci       Date:  2014-11-09       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.